Exelixis Net Income 2006-2020 | EXEL

Exelixis annual/quarterly net income history and growth rate from 2006 to 2020. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Exelixis net income for the quarter ending December 31, 2020 was $0.028B, a 58.7% decline year-over-year.
  • Exelixis net income for the twelve months ending December 31, 2020 was $0.112B, a 65.18% decline year-over-year.
  • Exelixis annual net income for 2020 was $0.112B, a 65.18% decline from 2019.
  • Exelixis annual net income for 2019 was $0.321B, a 53.48% decline from 2018.
  • Exelixis annual net income for 2018 was $0.69B, a 347.44% increase from 2017.
Exelixis Annual Net Income
(Millions of US $)
2020 $112
2019 $321
2018 $690
2017 $154
2016 $-70
2015 $-162
2014 $-261
2013 $-245
2012 $-148
2011 $76
2010 $-92
2009 $-135
2008 $-163
2007 $-86
2006 $-101
2005 $-84
Exelixis Quarterly Net Income
(Millions of US $)
2020-12-31 $28
2020-09-30 $-32
2020-06-30 $67
2020-03-31 $49
2019-12-31 $69
2019-09-30 $97
2019-06-30 $79
2019-03-31 $76
2018-12-31 $360
2018-09-30 $127
2018-06-30 $87
2018-03-31 $116
2017-12-31 $38
2017-09-30 $81
2017-06-30 $18
2017-03-31 $17
2016-12-31 $35
2016-09-30 $-11
2016-06-30 $-35
2016-03-31 $-59
2015-12-31 $-38
2015-09-30 $-46
2015-06-30 $-43
2015-03-31 $-35
2014-12-31 $-51
2014-09-30 $-63
2014-06-30 $-73
2014-03-31 $-75
2013-12-31 $-71
2013-09-30 $-67
2013-06-30 $-62
2013-03-31 $-45
2012-12-31 $-52
2012-09-30 $-33
2012-06-30 $-36
2012-03-31 $-26
2011-12-31 $46
2011-09-30 $78
2011-06-30 $-21
2011-03-31 $-27
2010-12-31 $-18
2010-09-30 $-9
2010-06-30 $-23
2010-03-31 $-43
2009-12-31 $-29
2009-09-30 $-25
2009-06-30 $-45
2009-03-31 $-36
2008-12-31 $-38
2008-09-30 $-39
2008-06-30 $-45
2008-03-31 $-41
2007-12-31 $-20
2007-09-30 $-14
2007-06-30 $-29
2007-03-31 $-24
2006-12-31 $-25
2006-09-30 $-25
2006-06-30 $-24
2006-03-31 $-27
2005-12-31 $-25
2005-09-30 $-23
2005-06-30 $-10
2005-03-31 $-27
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $6.758B $0.988B
Exelixis, Inc. is a biopharmaceutical company committed to developing small molecule therapies for the treatment of cancer. Exelixis is focusing its development and commercialization efforts primarily on COMETRIQ? (cabozantinib), its wholly-owned inhibitor of multiple receptor tyrosine kinases. Another Exelixis-discovered compound, cobimetinib, a selective inhibitor of MEK, is being evaluated by Roche and Genentech (a member of the Roche Group) in a broad development program under a collaboration with Exelixis.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $137.408B 9.52
Amgen (AMGN) United States $129.906B 13.55
CSL (CSLLY) Australia $93.397B 0.00
Gilead Sciences (GILD) United States $76.967B 8.66
Illumina (ILMN) United States $64.110B 97.65
Moderna (MRNA) United States $61.260B 0.00
Vertex Pharmaceuticals (VRTX) United States $55.255B 23.49
Regeneron Pharmaceuticals (REGN) United States $48.270B 15.78
Biogen (BIIB) United States $41.569B 8.31
Alexion Pharmaceuticals (ALXN) United States $33.582B 13.08
BeiGene (BGNE) Cayman Islands $29.272B 0.00
Seagen (SGEN) United States $27.376B 46.93
BioNTech SE (BNTX) Germany $26.253B 0.00
Exact Sciences (EXAS) United States $23.017B 0.00
Genmab (GMAB) Denmark $22.200B 31.07
Genmab (GNMSF) Denmark $20.419B 4.84
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $20.393B 0.00
Horizon Therapeutics Public (HZNP) Ireland $20.368B 23.37
Bio-Rad Laboratories (BIO.B) United States $17.927B 57.05
Alnylam Pharmaceuticals (ALNY) United States $17.328B 0.00
Incyte (INCY) United States $17.293B 0.00
ARGENX SE-ADR (ARGX) Netherlands $15.655B 0.00
Novavax (NVAX) United States $14.720B 0.00
Guardant Health (GH) United States $14.714B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.056B 112.22
Bio-Techne Corp (TECH) United States $14.033B 80.38
Repligen (RGEN) United States $11.633B 127.95
QIAGEN (QGEN) Netherlands $11.388B 23.26
Mirati Therapeutics (MRTX) United States $10.102B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $9.481B 0.00
Ultragenyx Pharmaceutical (RARE) United States $9.476B 0.00
Denali Therapeutics (DNLI) United States $8.610B 276.15
Fate Therapeutics (FATE) United States $8.414B 0.00
Ascendis Pharma (ASND) Denmark $8.278B 0.00
Acceleron Pharma (XLRN) United States $8.204B 0.00
Vir Biotechnology (VIR) United States $7.978B 0.00
Adaptive Biotechnologies (ADPT) United States $7.876B 0.00
ACADIA Pharmaceuticals (ACAD) United States $7.785B 0.00
Sarepta Therapeutics (SRPT) United States $6.870B 0.00
Twist Bioscience (TWST) United States $6.696B 0.00
Halozyme Therapeutics (HALO) United States $6.121B 50.28
Blueprint Medicines (BPMC) United States $5.693B 18.74
NeoGenomics (NEO) United States $5.659B 728.14
Galapagos (GLPG) Belgium $5.403B 0.00
Certara (CERT) United States $5.301B 0.00
Beam Therapeutics (BEAM) United States $5.167B 0.00
Emergent Biosolutions (EBS) United States $5.117B 12.23
SWEDISH ORP BIO (BIOVF) Sweden $5.010B 15.75
Arena Pharmaceuticals (ARNA) United States $4.848B 0.00
China Biologic Products (CBPO) China $4.705B 30.49
I-Mab (IMAB) China $4.259B 0.00
SpringWorks Therapeutics (SWTX) United States $4.196B 0.00
Reata Pharmaceuticals (RETA) United States $4.171B 0.00
Berkeley Lights (BLI) United States $3.989B 0.00
Arvinas (ARVN) United States $3.791B 0.00
Apellis Pharmaceuticals (APLS) United States $3.648B 0.00
Insmed (INSM) United States $3.644B 0.00
Legend Biotech (LEGN) United States $3.588B 0.00
Intellia Therapeutics (NTLA) United States $3.572B 0.00
NantKwest (NK) United States $3.543B 0.00
MorphoSys AG (MOR) Germany $3.269B 118.33
Amicus Therapeutics (FOLD) United States $3.200B 0.00
Alkermes (ALKS) Ireland $3.032B 0.00
Viela Bio (VIE) United States $2.921B 0.00
Intra-Cellular Therapies (ITCI) United States $2.840B 0.00
Editas Medicine (EDIT) United States $2.750B 0.00
Sorrento Therapeutics (SRNE) United States $2.711B 0.00
Global Blood Therapeutics (GBT) United States $2.633B 0.00
Amarin (AMRN) Ireland $2.621B 0.00
PHARMA MAR SA (PHMMF) Spain $2.544B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.523B 0.00
Ligand Pharmaceuticals (LGND) United States $2.462B 46.61
Myriad Genetics (MYGN) United States $2.293B 0.00
Arcus Biosciences (RCUS) United States $2.289B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $2.253B 18.65
Vericel (VCEL) United States $2.219B 965.60
Genetron Holdings (GTH) China $2.173B 0.00
Inovio Pharmaceuticals (INO) United States $2.074B 0.00
Bluebird Bio (BLUE) United States $2.064B 0.00
Dicerna Pharmaceuticals (DRNA) United States $2.025B 0.00
NGM Biopharmaceuticals (NGM) United States $1.844B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.832B 0.00
Scholar Rock Holding (SRRK) United States $1.820B 0.00
Heska (HSKA) United States $1.781B 0.00
Pandion Therapeutics (PAND) United States $1.777B 0.00
Revance Therapeutics (RVNC) United States $1.748B 0.00
Seres Therapeutics (MCRB) United States $1.737B 0.00
Zymeworks (ZYME) Canada $1.675B 0.00
Frequency Therapeutics (FREQ) United States $1.660B 0.00
Sangamo Therapeutics (SGMO) United States $1.646B 0.00
UniQure (QURE) Netherlands $1.633B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.589B 0.00
Travere Therapeutics (TVTX) United States $1.573B 0.00
Precigen (PGEN) United States $1.565B 0.00
Castle Biosciences (CSTL) United States $1.533B 0.00
REGENXBIO (RGNX) United States $1.530B 0.00
Zealand Pharma (ZEAL) Denmark $1.525B 0.00
Bionano Genomics (BNGO) United States $1.491B 0.00
Antibe Therapeutics (ATBPF) Canada $1.486B 0.00
Alector (ALEC) United States $1.441B 0.00
Nurix Therapeutics (NRIX) United States $1.385B 0.00
MannKind (MNKD) United States $1.328B 0.00
Cytokinetics (CYTK) United States $1.326B 0.00
Codexis (CDXS) United States $1.311B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $1.290B 0.00
Adverum Biotechnologies (ADVM) United States $1.251B 0.00
Mersana Therapeutics (MRSN) United States $1.245B 0.00
Northwest Biotherapeutics (NWBO) United States $1.207B 0.00
Zealand Pharma (ZLDPF) Denmark $1.203B 0.00
Pliant Therapeutics (PLRX) United States $1.174B 0.00
Coherus BioSciences (CHRS) United States $1.170B 9.61
Avid Bioservices (CDMO) United States $1.167B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $1.142B 0.00
Athenex (ATNX) United States $1.129B 0.00
Mesoblast (MESO) Australia $1.128B 0.00
Morphic Holding (MORF) United States $1.125B 0.00
MiMedx (MDXG) United States $1.100B 0.00
Celldex Therapeutics (CLDX) United States $1.071B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $1.071B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.024B 43.37
Syndax Pharmaceuticals (SNDX) United States $0.998B 0.00
Epizyme (EPZM) United States $0.976B 0.00
Dynavax Technologies (DVAX) United States $0.964B 0.00
G1 THERAPEUTICS (GTHX) United States $0.927B 0.00
Cara Therapeutics (CARA) United States $0.914B 229.38
Cellectis S.A (CLLS) France $0.913B 0.00
Protagonist Therapeutics (PTGX) United States $0.902B 0.00
Prothena (PRTA) Ireland $0.891B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.871B 0.00
ChromaDex (CDXC) United States $0.861B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.857B 0.00
Sutro Biopharma (STRO) United States $0.857B 0.00
Five Prime Therapeutics (FPRX) United States $0.846B 0.00
Pharming Group (PHGUF) Netherlands $0.832B 22.17
VBI Vaccines (VBIV) United States $0.816B 0.00
Kadmon Holdings (KDMN) United States $0.787B 0.00
AnaptysBio (ANAB) United States $0.785B 0.00
Agenus (AGEN) United States $0.761B 0.00
Cel-Sci (CVM) United States $0.719B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.715B 0.00
Merus (MRUS) Netherlands $0.711B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.678B 0.00
Starpharma Holdings (SPHRY) Australia $0.672B 0.00
ALBIREO PHARMA (ALBO) United States $0.665B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.654B 0.00
Sinovac Biotech (SVA) China $0.640B 35.94
Compugen (CGEN) Israel $0.638B 0.00
Precision BioSciences (DTIL) United States $0.628B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.623B 0.00
DBV Technologies S.A (DBVT) France $0.588B 0.00
Curis (CRIS) United States $0.579B 0.00
MeiraGTx Holdings (MGTX) United States $0.570B 0.00
Geron (GERN) United States $0.556B 0.00
AC Immune SA (ACIU) Switzerland $0.545B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.538B 0.00
Clovis Oncology (CLVS) United States $0.529B 0.00
Amryt Pharma (AMYT) United Kingdom $0.527B 0.00
Anika Therapeutics (ANIK) United States $0.522B 70.58
Gritstone Oncology (GRTS) United States $0.512B 0.00
Neoleukin Therapeutics (NLTX) United States $0.505B 0.00
Affimed (AFMD) Germany $0.501B 0.00
AquaBounty Technologies (AQB) United States $0.499B 0.00
Spero Therapeutics (SPRO) United States $0.494B 0.00
CorMedix Inc (CRMD) United States $0.482B 0.00
AMMO (POWW) United States $0.480B 0.00
Syros Pharmaceuticals (SYRS) United States $0.472B 0.00
WAVE Life Sciences (WVE) Singapore $0.459B 0.00
Selecta Biosciences (SELB) United States $0.456B 0.00
BioDelivery Sciences (BDSI) United States $0.425B 20.00
Kala Pharmaceuticals (KALA) United States $0.416B 0.00
Cue Biopharma (CUE) United States $0.412B 0.00
Athersys (ATHX) United States $0.403B 0.00
XOMA (XOMA) United States $0.399B 0.00
Verastem (VSTM) United States $0.399B 0.00
Opthea (OPT) Australia $0.399B 0.00
UROGEN PHARMA (URGN) United States $0.398B 0.00
Puma Biotechnology (PBYI) United States $0.396B 0.00
IBio (IBIO) United States $0.380B 0.00
Oncobiologics (OTLK) United States $0.376B 0.00
Forte Biosciences (FBRX) United States $0.366B 0.00
Cardiff Oncology (CRDF) United States $0.365B 0.00
CytomX Therapeutics (CTMX) United States $0.363B 0.00
Innate Pharma S.A (IPHA) France $0.363B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.360B 0.00
ANI Pharmaceuticals (ANIP) United States $0.360B 9.15
Aeglea BioTherapeutics (AGLE) United States $0.357B 0.00
Fortress Biotech (FBIO) United States $0.349B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.345B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.341B 0.00
Trevena (TRVN) United States $0.337B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.336B 0.00
Arbutus Biopharma (ABUS) United States $0.318B 0.00
NextCure (NXTC) United States $0.313B 0.00
Theratechnologies (THTX) Canada $0.301B 0.00
Bellus Health (BLU) Canada $0.299B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.295B 0.00
PDL BioPharma (PDLI) United States $0.282B 0.00
Kamada (KMDA) Israel $0.273B 15.74
HOOKIPA Pharma (HOOK) United States $0.259B 0.00
Cerecor (CERC) United States $0.252B 0.00
Abeona Therapeutics (ABEO) United States $0.238B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.238B 0.00
OSMOTICA PHARM (OSMT) United States $0.238B 0.00
Aptinyx (APTX) United States $0.232B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.229B 0.00
TELA Bio (TELA) United States $0.222B 0.00
ADMA Biologics Inc (ADMA) United States $0.218B 0.00
Checkpoint Therapeutics (CKPT) United States $0.218B 0.00
Applied Genetic Technologies (AGTC) United States $0.217B 0.00
Voyager Therapeutics (VYGR) United States $0.212B 5.97
Strongbridge Biopharma (SBBP) United States $0.211B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.202B 0.00
Pluristem Therapeutics (PSTI) Israel $0.200B 0.00
VolitionRX (VNRX) United States $0.197B 0.00
POXEL SA FRANCE (PXXLF) France $0.197B 0.00
VTv Therapeutics (VTVT) United States $0.197B 0.00
GENFIT S.A (GNFT) France $0.194B 0.00
Eton Pharmaceuticals (ETON) United States $0.192B 0.00
Exicure (XCUR) United States $0.190B 0.00
Palatin Technologies (PTN) United States $0.180B 0.00
Protalix BioTherapeutics (PLX) Israel $0.180B 0.00
Kindred Biosciences (KIN) United States $0.178B 0.00
Nicox SA (NICXF) France $0.177B 0.00
DiaMedica Therapeutics (DMAC) United States $0.172B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.168B 0.00
Orgenesis (ORGS) United States $0.162B 334.50
Clearside Biomedical (CLSD) United States $0.160B 0.00
Seelos Therapeutics (SEEL) United States $0.159B 0.00
Biofrontera AG (BFRA) Germany $0.156B 0.00
Idera Pharmaceuticals (IDRA) United States $0.154B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.152B 0.00
Cogent Biosciences (COGT) United States $0.152B 0.00
Evogene (EVGN) Israel $0.151B 0.00
Dyadic (DYAI) United States $0.146B 0.00
Aptevo Therapeutics (APVO) United States $0.143B 0.00
Liminal BioSciences (LMNL) Canada $0.141B 0.00
Enzo Biochem (ENZ) United States $0.140B 0.00
Aytu Bioscience (AYTU) United States $0.137B 0.00
Catalyst Biosciences (CBIO) United States $0.133B 0.00
Synlogic (SYBX) United States $0.132B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.132B 0.00
Prima BioMed (IMMP) Australia $0.131B 0.00
Cyclerion Therapeutics (CYCN) United States $0.130B 0.00
TRACON Pharmaceuticals (TCON) United States $0.128B 0.00
Beyond Air (XAIR) United States $0.121B 0.00
Liquidia Technologies (LQDA) United States $0.121B 0.00
CytRx (CYTR) United States $0.118B 0.00
PHASEBIO PHARMA (PHAS) United States $0.114B 0.00
Lumos Pharma (LUMO) United States $0.113B 0.00
ARAVIVE, INC (ARAV) United States $0.110B 0.00
Cocrystal Pharma (COCP) United States $0.108B 0.00
Ecology Coatings (ABVC) United States $0.107B 0.00
Celyad SA (CYAD) Belgium $0.106B 0.00
Cidara Therapeutics (CDTX) United States $0.100B 0.00
AIkido Pharma (AIKI) United States $0.097B 0.00
Novogen (KZIA) Australia $0.095B 0.00
Advaxis (ADXS) United States $0.094B 0.00
Adocia (ADOCY) France $0.092B 0.00
Organovo Holdings (ONVO) United States $0.091B 0.00
Stealth BioTherapeutics (MITO) United States $0.090B 40.75
Vascular Biogenics (VBLT) Israel $0.087B 0.00
AEterna Zentaris (AEZS) United States $0.087B 0.00
Windtree Therapeutics (WINT) United States $0.086B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.084B 0.00
Vaccinex (VCNX) United States $0.083B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.082B 0.00
Cleveland BioLabs (CBLI) United States $0.077B 0.00
Celsion (CLSN) United States $0.077B 0.00
Purple Biotech (PPBT) Israel $0.075B 0.00
AnPac Bio-Medical Science (ANPC) China $0.074B 0.00
Emmaus Life Sciences (EMMA) United States $0.069B 0.00
Genetic Technologies (GENE) Australia $0.066B 0.00
ARIDIS PHARMACT (ARDS) United States $0.064B 0.00
Edesa Biotech (EDSA) Canada $0.061B 0.00
Pulmatrix (PULM) United States $0.056B 0.00
Appili Therapeutics (APLIF) Canada $0.053B 0.00
Enveric Biosciences (ENVB) United States $0.052B 0.00
Soligenix (SNGX) United States $0.052B 0.00
Happiness Biotech Group (HAPP) China $0.052B 0.00
BioCardia (BCDA) United States $0.048B 0.00
Acorda Therapeutics (ACOR) United States $0.047B 0.00
Yumanity Therapeutics (YMTX) United States $0.046B 0.00
ATyr Pharma (LIFE) United States $0.044B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.042B 0.00
Alimera Sciences (ALIM) United States $0.041B 0.00
IMMURON (IMRN) Australia $0.038B 0.00
Prana Biotechnology (ATHE) Australia $0.036B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.034B 0.00
Lexaria Bioscience (LEXX) Canada $0.031B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.030B 0.00
Titan Pharmaceuticals (TTNP) United States $0.024B 0.00
Seneca Biopharma (SNCA) United States $0.023B 0.00
GeoVax Labs (GOVX) United States $0.022B 0.00
ThermoGenesis Holdings (THMO) United States $0.022B 0.00
Timber Pharmaceuticals (TMBR) United States $0.022B 0.00
Invo BioScience (INVO) United States $0.016B 0.00
Benitec Biopharma (BNTC) United States $0.015B 0.00
Cyclo Therapeutics (CYTH) United States $0.014B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
Viridian Therapeutics (VRDN) United States $0.000B 0.00
Zai Lab (ZLAB) China $0.000B 0.00